Renal-Related Deaths Rise Among Substance Use Patients
Data shows a 14-fold increase in annual deaths tied to renal failure and substance use among adults between 1999 and 2024.
Updated on Oct. 24, 2026 in Substance Abuse
Live Poll
Should medical systems prioritize specialized care for patients with both kidney disease and substance use disorders?
Annual U.S. deaths linked to renal failure and substance use disorder increased 14-fold between 1999 and 2024. These findings, based on a total of 45,273 recorded deaths, highlight a significant shift in mortality patterns related to substance use.
Why it matters
Understanding this long-term trend in renal-related substance use deaths is critical for public health, as it reveals changing risks and settings where these outcomes occur. The data provides a baseline for addressing care access and prevention strategies across the country.
This retrospective study analyzed 45,273 deaths from 1999 to 2024 using the CDC WONDER database to track cases involving kidney failure and substance use. While documenting a clear 14-fold rise in annual mortality, the research does not establish the specific clinical drivers for these cases.
The players
CDC WONDER
A database system maintained by the Centers for Disease Control and Prevention that provides public access to detailed U.S. mortality and population statistics.
The details
Researchers examined death records listing acute kidney failure, chronic kidney disease, or unspecified kidney failure alongside substance use disorder as the underlying cause. Over the 25-year study period, deaths increased at an annual rate of 11.34%, with 55% of all recorded deaths occurring in in-patient settings. Home-based deaths also rose during this timeframe at an annual rate of 15.37%.
Timeline
1999: The study period began, recording 186 deaths linked to renal failure and substance use.
2022: Annual deaths peaked at 2,875 during the study period.
2024: The study period concluded, with 2,615 deaths recorded annually.
Health Landscape
This trend of increasing renal-related fatalities mirrors the trajectory observed in the broader U.S. opioid overdose crisis. The data underscores an evolving mortality landscape that necessitates a wider focus on organ-specific complications associated with substance use disorders.
This data highlights the importance of discussing kidney function and substance use patterns with a primary care physician to identify early warning signs. Individuals managing these conditions should monitor their renal health consistently and ensure they remain connected to specialty care services.
The takeaway
These mortality trends emphasize the need for integrated care models that address both substance use disorders and chronic health complications like renal failure. Patients should consult their doctor about regular kidney function screenings if they are managing a substance use disorder.
Further reading
For more on the national response to drug-related health outcomes, visit the Substance Abuse section.
Source note: This article includes information reported by Healio.
Live Poll
Should medical systems prioritize specialized care for patients with both kidney disease and substance use disorders?
